About Index Trending news
Analyze
Pricing
Casdin Capital

Casdin Capital

Casdin Capital

Casdin Capital, LLC is an investment firm focused on disruptive businesses in the life sciences and healthcare industry.
I work here Suggest edits
More info

Elsewhere

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 13

Portfolio

Portfolio tracker
Add info

Investment profile

Target markets
Health Care Biotechnology

Activity

Past year's investments

Casdin Capital participated in fewer than 3 rounds over the past year.

Latest rounds

- Magenta Therapeutics: Venture capital (Series B) ($50M)
- Clover Health: Venture capital (Series C) ($160M)
- Syros Pharmaceuticals: Venture capital (Series C) ($40M)

Main Co-investors

- Redmile Group
- Deerfield Capital Management
- Third Rock Ventures

23andMe

23andMe

Search +1
Total funding
$428.8M in 10 rounds from 25 investors
By Casdin Capital
$115M Series E in Jul, 2015
Syros Pharmaceuticals

Syros Pharmaceuticals

Biotechnology
Total funding
$123M in 3 rounds from 13 investors
By Casdin Capital
$40M Series C in Jan, 2016
Flatiron Health

Flatiron Health

Health and Wellness +1
Total funding
$314.4M in 4 rounds from 17 investors
By Casdin Capital
$175M Series C in Jan, 2016
Editas Medicine

Editas Medicine

Biotechnology
Total funding
$257M in 3 rounds from 17 investors
By Casdin Capital
$120M Series B in Aug, 2015
Clover Health

Clover Health

Health Care +1
Total funding
$295M in 3 rounds from 19 investors
By Casdin Capital
$160M Series C in May, 2016
Foundation Medicine

Foundation Medicine

United States
Total funding
$76M in 2 rounds from 10 investors
By Casdin Capital
$42.5M Series B in Sep, 2012
Invitae

Invitae

Health Care +1
Total funding
$160M in 2 rounds from 19 investors
By Casdin Capital
$120M Series F in Oct, 2014
Blueprint Medicines

Blueprint Medicines

Health Care +1
Total funding
$240M in 4 rounds from 16 investors
By Casdin Capital
$25M Series B in Jan, 2014
Omicia

Omicia

Big Data +3
Total funding
$29.8M in 2 rounds from 12 investors
By Casdin Capital
$6.8M Series A in Jan, 2014
Exit Spiral Genetics, Jan 23, 2017
MyoKardia

MyoKardia

Biotechnology
Total funding
$94M in 3 rounds from 7 investors
By Casdin Capital
$46M Series B in Apr, 2015
Jounce Therapeutics

Jounce Therapeutics

Biotechnology
Total funding
$158M in 2 rounds from 9 investors
By Casdin Capital
$56M Series B in Apr, 2015
Magenta Therapeutics

Magenta Therapeutics

Biotechnology
Total funding
$98.5M in 2 rounds from 11 investors
By Casdin Capital
$50M Series B in May, 2017

Want to see the complete list?
Go Pro!